Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2618-2624, May 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Constantinou, A.
Right arrow Articles by Huberman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Constantinou, A.
Right arrow Articles by Huberman, E.

Induction of Differentiation and DNA Strand Breakage in Human HL-60 and K-562 Leukemia Cells by Genistein1

Andreas Constantinou, Kaoru Kiguchi and Eliezer Huberman2

Biological and Medical Research Division, Argonne National Laboratory, Argonne, IL 60439

Genistein, an in vitro inhibitor of topoisomerase II and tyrosine kinases, suppressed growth and induced differentiation in HL-205 cells, a clonal population of the human promyelocytic HL-60 leukemia cells, and in K-562-J cells, a clonal population of the human erythroid K-562 leukemia cells. Maturing HL-205 cells acquired either granulocytic or monocytic markers, namely, reactivity with the murine OKM1 monoclonal antibody, expression of nitroblue tetrazolium dye reduction, and staining for nonspecific esterase. The maturing K-562-J cells stained with benzidine, which indicates the presence of hemoglobin, an erythroid maturation marker. Although the acquisition of the maturation markers in both HL-205 and K-562-J cells was time dependent up to 6 days, the kinetics of this induction differed between the two cell types. Despite the in vitro inhibitory effect of genistein, treatment of either HL-205 or K-562-J cells with 150 µg/ml genistein for up to 16 h did not alter topoisomerase II activity (as determined by the unknotting assay) in their nuclear extracts. Analysis with the anti-phosphotyrosine PY-20 murine monoclonal antibody indicated that treatment of K-562-J cells with genistein decreased the reactivity of the antibody with two of the cellular proteins. However, no reactivity with the PY-20 antibody was detected in untreated or genistein-treated HL-205 cells. An early event in the HL-205 and K-562-J cells, occurring after only 1 h of treatment with 30–200 µg/ml genistein, was the induction of DNA damage as measured by an alkaline elution assay. This damage may be a contributing factor in the genistein-induced cell differentiation in the HL-205 and K-562-J cells.

1 This work was supported by the U.S. Department of Energy, Office of Health and Environmental Research, under contract W-31-109-ENG-38.

2 To whom requests for reprints should be addressed, at Biological and Medical Research Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439.

Received 8/11/89. Revised 12/20/89.


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
M. Messina, W. McCaskill-Stevens, and J. W. Lampe
Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
D. G. Gilliland, C. T. Jordan, and C. A. Felix
The Molecular Basis of Leukemia
Hematology, January 1, 2004; 2004(1): 80 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Wei, R. Saladi, Y. Lu, Y. Wang, S. R. Palep, J. Moore, R. Phelps, E. Shyong, and M. G. Lebwohl
Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology
J. Nutr., November 1, 2003; 133(11): 3811S - 3819.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. E. Piersen
Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer
Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Li and F. H. Sarkar
Inhibition of Nuclear Factor {kappa}B Activation in PC3 Cells by Genistein Is Mediated via Akt Signaling Pathway
Clin. Cancer Res., July 1, 2002; 8(7): 2369 - 2377.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Messina and C. L. Loprinzi
Soy for Breast Cancer Survivors: A Critical Review of the Literature
J. Nutr., November 1, 2001; 131(11): 3095S - 3108.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L.-J. W. Lu, K. E. Anderson, J. J. Grady, and M. Nagamani
Effects of an Isoflavone-Free Soy Diet on Ovarian Hormones in Premenopausal Women
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3045 - 3052.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun
Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells
J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. J Messina
Legumes and soybeans: overview of their nutritional profiles and health effects
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Gozlan, J. L. Lathey, and S. A. Spector
Human Immunodeficiency Virus Type 1 Induction Mediated by Genistein Is Linked to Cell Cycle Arrest in G2
J. Virol., October 1, 1998; 72(10): 8174 - 8180.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin
Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
PNAS, August 19, 1997; 94(17): 8982 - 8987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Vera, A. M. Reyes, J. G. Cárcamo, F. V. Velásquez, C. I. Rivas, R. H. Zhang, P. Strobel, R. Iribarren, H. I. Scher, J. C. Slebe, et al.
Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1
J. Biol. Chem., April 12, 1996; 271(15): 8719 - 8724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N.-S. Chang and N. S. Chang
Transforming Growth Factor-beta1 Induction of Novel Extracellular Matrix Proteins That Trigger Resistance to Tumor Necrosis Factor Cytotoxicity in Murine L929 Fibroblasts
J. Biol. Chem., March 31, 1995; 270(13): 7765 - 7772.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Strick, P. L. Strissel, S. Borgers, S. L. Smith, and J. D. Rowley
From the Cover: Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
PNAS, April 25, 2000; 97(9): 4790 - 4795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.